GSK takes over Novartis' troubled OTC plant; China wants drug distribution reforms;

> GlaxoSmithKline ($GSK) now has control of the troubled Novartis ($NVS) OTC plant in Lincoln, NE, as part of their new consumer health JV. Story

> Mapi Group has added pharma regulatory consulting services, CanReg Group, after its acquisition this year of the North American and European regulatory consulting services of Optum Life Sciences. Release

> China's government is suggesting drugmakers cut middlemen out of the processing selling their drugs in an effort to cut costs and reduce corruption. Story

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.